Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-13

Clinical Trial Update: Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating safety and tolerability of Sativex in cancer-related pain; completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sativex (nabiximol)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Pain, Cancer | Phase 3 | Status: COMPLETED | Results posted: 2012-09-13